Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

488
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
488
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

160
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
160
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

189
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
189
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

108
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
108
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

141
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
141
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Improving hit discovery by integrating activity cliff sensitivity into active learning.

Bioinformatics (Oxford, England)·2026
Same author

A thermosensitive TET-Parkin epigenetic axis couples mitochondrial quality control to adaptive thermogenesis in adipose tissue.

Metabolism: clinical and experimental·2026
Same author

Validation of a 2-Gene Blood Test for Kawasaki Disease in Febrile Children.

JAMA network open·2026
Same author

Deep learning for predicting patient drug response by transferring gene-level and cell-level knowledge to tumors.

NPJ precision oncology·2026
Same author

Coronary Computed Tomographic Angiography Versus Functional Testing in Patients With Newly Diagnosed Type 2 Diabetes and Suspected Coronary Artery Disease: Real-world Evidence from the Nationwide Cohort.

Korean circulation journal·2026
Same author

Effects of Maternal Tetramethyl Bisphenol F Exposure on Neurodevelopment and Behavior in Mouse Offspring.

International journal of molecular sciences·2026

相关实验视频

Updated: Jul 5, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

双重表示学习用于预测药物副作用频率,使用蛋白质目标信息.

Sungjoon Park, Sangseon Lee, Minwoo Pak

    IEEE journal of biomedical and health informatics
    |January 19, 2024
    PubMed
    概括

    这项研究引入了一种新的深度学习模型,用于预测药物副作用的频率,其性能优于现有的方法,特别是在新药方面. 它有效地整合了各种药物特征,以提高药物监测和药物重定向的准确性.

    科学领域:

    • 药理学 药理学是指药理学的学科.
    • 计算生物学 计算生物学
    • 人工智能在医学中的应用

    背景情况:

    • 了解药物的副作用对于治疗风险评估和药物的重新用途至关重要.
    • 预测药物副作用的现有方法往往无法预测药物副作用的频率,处理未见的药物或利用各种药物特征.
    • 目前的预测模型缺乏药物标信息的整合,限制了它们的全面适用性.

    研究的目的:

    • 开发一种新的深度学习模型,用于预测药物副作用频率.
    • 通过整合异质药物特征,提高已知和未见药物的预测准确度.
    • 通过提供更准确的副作用频率预测,增强药物重定向和药监.

    主要方法:

    • 开发了一个深度学习模型,使用异质药物特征来预测药物副作用频率,包括目标蛋白信息,分子图,指纹和化学相似性.
    • 该模型同时创建药物嵌入,并在一个共同的矢量空间中学习药物和副作用的双重表示向量.
    • 使用Adaboost方法将模型的预测能力扩展到缺乏明确标蛋白的药物.

    主要成果:

    • 拟议的模型在预测药物副作用频率方面取得了最先进的性能,显著超过现有方法.
    • 该模型表现出卓越的预测能力,特别是对于未见的药物,突出其稳定性和通用性.

    更多相关视频

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.9K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.6K

    相关实验视频

    Last Updated: Jul 5, 2025

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    2.5K
    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.9K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.6K
  • 废弃性研究证实了异质药物特征的有效整合和利用,具有明确标的药物显示出更好的预测准确性.
  • 结论:

    • 新的深度学习模型在预测药物副作用频率方面取得了重大进展,解决了以前方法的局限性.
    • 多种药物特征的整合和双重表示学习有助于模型的高精度和对新药的概括能力.
    • 这种方法有望改善药物安全监测,风险评估,并促进有效的药物重定向努力.